Central sensitization and ilness perceptions should be taken into account when interpreting disease activity in patients axial spondyloarthritis. S. Kieskamp, D. Paap, M.J.G. Carbo, F. Wink, R. Bos, H. Bootsma, S. Arends, A. Spoorenberg. Rheumatology. Accepted for publication
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial. Molto, C. Lopez-Medina, F. van den Bosch, A. Boonen, C. Webers, E. Dernis, F. van Gaalen, M. Soubrier, P. Claudepierre, A. Baillet, M. Starsman-Kool, A. Spoorenberg, P. Jacques, P. Carron, R. Joos, J. Lenearts, L. Gosses, S. Pouplin, A. Ruyssen-Witrand, L. Sparsa, A. van Tubergen, D. van der Heijde, M. Dougados. Ann Rheum Dis. Accepted for publication.
Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis. S. Arends, F. Wink, J. Veneberg, R. Bos, E. van Roon, E. van der Veer, F. Maas, A. Spoorenberg. Br J Clin Pharmacol. 2020 Jun 12 [Epub ahead of print]
The IMPACT study: a clustered randomized controlled trial to assess the effect of a referral algorithm for axial spondyloarthritis. M. Jamal, A.M. Korver, M. Kuijper, D. Lopes Barreto, C.W.Y. Appels, A. Spoorenberg, B.W. Koes, J.M.W. Hazes, L.V. Hoeven, A.E.A.M. Weel. PLoS One. 2020;15(1):e0227025.